Automatic Quantitative Analysis software for Alzheimer’s Disease

Heuron-Alzheimer provides information by PET & 3D T1 MRI-based imaging for Alzheimer's Disease. This solution automatically quantifies multi-tracer bindings localized to 97 brain segmentation and 4 reference regions identified by 3D T1 MRI segmentation.  
  • FDA, CE, MFDS approved
  • Commercially available

Amyloid beta, biomarker for Alzheimer's Disease

Alzheimer's Disease(AD) pathogenesis  is widely believed to be driven by the production
and deposition of the amyloid beta plaque.

Amyloid beta is the first protein that begins to accumulate when Alzheimer's
Disease(AD) is contracted, and it is used as an important biomarker in diagnosing Alzheimer's Disease(AD) .

'Heuron-Alzheimer' analyzes amyloid PET images and presents quantitative results to support diagnosis and clinical trials.